Close this search box.

BIOTECanada Hosts Annual General Meeting and Announces New Chair of the Board of Directors – BIOTECanada

May 31, 2024

[OTTAWA] Following BIOTECanada’s Annual General Meeting, the Board of Directors is pleased to announce Oliver Technow, CEO, BioVectra Inc. as the incoming Chair of the Board, succeeding Gordon McCauley, President and CEO of adMare BioInnovations whose term as Chair has concluded.

Technow brings over 30 years of experience in the global biosciences sector and a proven track record as CEO of BioVectra Inc., a Charlottetown-based, global Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical and biotech companies with full-service solutions for active pharmaceutical ingredients (API) and intermediates.

“Oliver brings unique expertise and leadership to BIOTECanada’s Board of Directors. His deep industry knowledge and strategic insight will greatly benefit the organization as we continue to call for investment in the sector, the modernization of regulatory decision-making, and support for a healthy biotech ecosystem leading to increased research, development, and company growth,” said Andrew Casey, President & CEO, BIOTECanada.

“On behalf of the BIOTECanada team and its member companies, I extend deep gratitude to Gordon for his dedicated service as Chair of the Board of Directors. His leadership, dedication, and expertise have been invaluable to the organization. Under his stewardship, BIOTECanada has achieved significant milestones including the launch of the biomanufacturing and life sciences strategy, as well as a focus on increasing investment to the sector. The entire BIOTECanada team greatly appreciates Gordon’s leadership over his term as Chair.” said Casey.

BIOTECanada thanks departing board members, Tracey Ramsay, Vice President and General Manager, AbbVie Canada; Maha Katabi, General Partner, Sofinnova Ventures; and Alok Kanti, General Manager, Bayer Canada for their service.

BIOTECanada’s Board of Directors is a true reflection of its diverse membership, showcasing the broader landscape of the Canadian biotech ecosystem. For a full list of BIOTECanada’s Board of Directors, visit: BIOTECanada Board of Directors.


Nina Lewis
Communications Manager

BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges. Visit: